Acute rheumatic fever in Konya, Turkey.
BACKGROUND
Patients with acute rheumatic fever (ARF), who were admitted to Pediatric Cardiology Unit of Selçuk University Faculty of Medicine from July 1993 to 1998, were studied retrospectively to verify the clinical profile of the disease and to compare the results with those from other countries.


METHODS
All patients were examined by one of the two pediatric cardiologists in our study group. Every patient had a chest X-ray, electrocardiogram and an echocardiographic investigation. Throat culture, antistreptolysin O test, C-reactive protein and sedimentation rates were investigated for each patient.


RESULTS
During the study period, 274 cases with ARF were identified among patients admitted to the present institution. There were 8032 visits during the study period, giving an occurrence rate of 3.4%. Arthritis was the most common major manifestation (81.4%). It was followed by carditis (60.9%) and chorea (17.9%). Subcutaneous nodules (0.7%) and erythema marginatum (0.4%) were both seen in patients with carditis. The mitral valve was the most commonly affected valve (95.8%), followed by the aortic valve (40.1%). Two patients died and regurgitation disappeared in 21% of patients with mitral regurgitation. Fifteen patients (14%) with isolated arthritis and pure chorea had mitral regurgitation demonstrated by echocardiographic investigation but without any significant murmur.


CONCLUSIONS
The present study indicates that ARF is still a significant problem in Konya and that recurrences can be prevented by administering a 3-week benzathine penicillin G regimen.
Karaaslan
S
S
Department of Pediatrics, Faculty of Medicine, Selçuk University, Konya, Turkey.
Oran
B
B
Reisli
I
I
Erkul
I
I
D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000209:etiology; D010401:Penicillin G Benzathine / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use*; D012189:Retrospective Studies; D012213:Rheumatic Fever / Q000150:complications / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D055502:Secondary Prevention; D014421:Turkey / Q000453:epidemiology
D010406:Penicillins; D010401:Penicillin G Benzathine